KÄÄPÄ Biotech is a biotechnology company committed to healthier humans and ecosystems. The company researches, innovates and develops novel industry solutions with fungi.
EU Approves KÄÄPÄ Biotech’s NordRelease™ Extract Powders
Landmark Decision Unequivocally Places KÄÄPÄ Biotech as the Leading European Functional Mushroom Provider
Karjalohja, Finland, 23.04.2025 - KÄÄPÄ Biotech, a biotechnology company that researches, innovates and develops functional mushroom products, today announced that the European Food Safety Authority (EFSA) has evaluated and validated their NordRelease™ extraction process for mushroom extracts.
KÄÄPÄ Biotech Closes Strategic Investment from PeakBridge
PeakBridge invested €900,000 in the Growing Biotechnology Company .Karjalohja, Finland, 08.04.2025 - KÄÄPÄ Biotech, a biotechnology company that researches, innovates and develops functional mushroom products, today announced it has closed a €900,000 strategic investment from PeakBridge, a pioneering global fund manager in agri-food and a member of the Edmond de Rothschild Private Equity partnership. The funding will be used to further enable KÄÄPÄ Biotech to scale its business to meet customer demand, and help bring functional mushroom ingredients to the forefront of global wellness.
Kääpä Biotech Oy has successfully concluded their Food Safety System Certification (FSSC 22000) project
KÄÄPÄ Biotech has won the Start-up Award in the NutraIngredients Awards 2021
"NutraIngredients Awards is a respected competition within the nutraceutical and food supplement industry. Winning the Start-up category is a great honor. This is a significant recognition for our several years’ work and dedication to change the medicinal mushroom industry standards towards more sustainable and responsible practices". Eric Puro, CEO of KÄÄPÄ Biotech.